These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1854130)
21. [Estrogens, progestins and the bone]. Ribot C Rev Prat; 1993 Dec; 43(20):2619-23. PubMed ID: 8146561 [TBL] [Abstract][Full Text] [Related]
22. HRT in the prevention and treatment of osteoporosis. Delmas PD J Epidemiol Biostat; 1999; 4(3):155-60; discussion 160-3. PubMed ID: 10695957 [TBL] [Abstract][Full Text] [Related]
23. [The role of estrogens in bone metabolism in women after menopause]. Radowicki S; Dowgiałło-Smolarczyk J; Wiśniewska-Sawicka E Pol Tyg Lek; 1993 Nov; 48 Suppl 3():10-2. PubMed ID: 8309828 [TBL] [Abstract][Full Text] [Related]
25. Drugs for prevention and treatment of postmenopausal osteoporosis. Treat Guidel Med Lett; 2005 Oct; 3(38):69-74. PubMed ID: 16177651 [No Abstract] [Full Text] [Related]
26. Endocrinological status of postmenopausal osteoporosis. Nagant de Deuxchaisnes C; Devogelaer JP Clin Rheum Dis; 1986 Dec; 12(3):559-635. PubMed ID: 3078776 [TBL] [Abstract][Full Text] [Related]
27. Calcitonin reserve and the differentiated response to calcitonin in osteoporosis. Vlăduţiu T; Lopez A; Gozariu L; Barabaş E Endocrinologie; 1990; 28(3-4):139-47. PubMed ID: 2103972 [TBL] [Abstract][Full Text] [Related]
28. Calcitonin and the treatment of osteoporosis. Schneyer CR Md Med J; 1991 Jun; 40(6):469-73. PubMed ID: 1861574 [TBL] [Abstract][Full Text] [Related]
29. Use of calcitonin in 20 patients suffering from postmenopausal osteoporosis. A proposal for a therapeutical scheme. Lanciani P; Porzio V; Cattani D Panminerva Med; 1991; 33(2):119-20. PubMed ID: 1923555 [TBL] [Abstract][Full Text] [Related]
31. Postmenopausal osteoporosis and hormone replacement therapy. Gambacciani M; Vacca F Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435 [TBL] [Abstract][Full Text] [Related]
32. [Treatment of osteoporosis with antiresorptive drugs]. Vestergaard P; Mosekilde L; Brixen K Ugeskr Laeger; 2005 Feb; 167(8):883-7. PubMed ID: 15789840 [No Abstract] [Full Text] [Related]
33. Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial. Lufkin EG; Sarkar S; Kulkarni PM; Ciaccia AV; Siddhanti S; Stock J; Plouffe L Curr Med Res Opin; 2004 Mar; 20(3):351-7. PubMed ID: 15025844 [TBL] [Abstract][Full Text] [Related]
34. Postmenopausal osteoporosis and estrogen. Nelson HD Am Fam Physician; 2003 Aug; 68(4):606, 610, 612. PubMed ID: 12952379 [No Abstract] [Full Text] [Related]
35. [Osteoporosis of the lumbar spine]. Villiger PM; Krapf R Praxis (Bern 1994); 1996 Oct; 85(43):1354-9. PubMed ID: 8966437 [TBL] [Abstract][Full Text] [Related]
36. [Sex hormones and osteoporosis: a physiological perspective for prevention and therapy]. da Silva JA; Porto A Acta Med Port; 1997 Oct; 10(10):689-95. PubMed ID: 9477594 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis. Stepan JJ; Alenfeld F; Boivin G; Feyen JH; Lakatos P Endocr Regul; 2003 Dec; 37(4):225-38. PubMed ID: 15106819 [TBL] [Abstract][Full Text] [Related]
38. [Osteoporosis treatment: the point of view of the gynecologist]. Lopes P Contracept Fertil Sex; 1998 Jun; 26(6):408-11. PubMed ID: 9691516 [No Abstract] [Full Text] [Related]
39. Alternative strategies for prevention of postmenopausal osteoporosis. Lindsay R Public Health Rep; 1989; 104 Suppl(Suppl):66-70. PubMed ID: 2517704 [TBL] [Abstract][Full Text] [Related]
40. [The role of calcitonin in treatment of osteoporosis]. Sawicki A Pol Tyg Lek; 1993 Nov; 48 Suppl 3():58-60. PubMed ID: 8309842 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]